Werewolf

Werewolf: Products & infrastructure

Werewolf has 3 clinical trials on record, 0 under way.

Data updated Nov 21, 2026 · Back to the company report

Products

Werewolf has 3 clinical trials on record, 0 under way.

3clinical trials
Clinical trialsthe studies it sponsors or works on, per ClinicalTrials.gov
A Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastat…
phase 2 · completed · 24 participants · Advanced or Metastatic Solid Tumors; Non-Hodgkin Lymphoma
Apr 2025
WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma
phase 1 · completed · 25 participants · Advanced or Metastatic Solid Tumors; Non-Hodgkin Lymphoma
Dec 2022
Dose Escalation and Expansion Study of WTX-124 as Monotherapy and in Combination With Pembrolizumab (Pembro) in Patient…
phase 1 · completed · 156 participants · Metastatic Solid Tumor; Advanced Solid Tumor
Aug 2022
Source: each app’s App Store and Google Play page (an app counts as the company’s when its developer site is on the company’s domain); the products its own site names.